ASX:COH - Cochlear Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
A$201.64 +0.10 (+0.05 %)
(As of 09/23/2018 04:00 PM ET)
Previous CloseA$201.64
Today's RangeA$201.33 - A$203.10
52-Week RangeA$129.18 - A$192.80
Volume248,425 shs
Average Volume194,422 shs
Market Capitalization$11.06 billion
P/E RatioN/A
Dividend Yield1.46%
BetaN/A
Cochlear logoCochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has a strategic collaboration with Sensorion to focus on improving hearing outcomes in patients with cochlear implants. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia.

Receive COH News and Ratings via Email

Sign-up to receive the latest news and ratings for COH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolASX:COH
CUSIPN/A
Phone+61-2-94286555

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins17.90%
Return on Equity41.48%
Return on Assets19.99%

Miscellaneous

EmployeesN/A
Outstanding Shares57,430,000
Market Cap$11.06 billion

Cochlear (ASX:COH) Frequently Asked Questions

What is Cochlear's stock symbol?

Cochlear trades on the ASX under the ticker symbol "COH."

Who are some of Cochlear's key competitors?

Who are Cochlear's key executives?

Cochlear's management team includes the folowing people:
  • Mr. Diggory William Howitt, CEO, MD, Pres & Exec. Director (Age 50)
  • Mr. Brent Andrew Cubis BComm, CA, Chief Financial Officer
  • Mr. Jan Janssen MSc Elec Eng, Chief Technology Officer
  • Mr. Richard Brook, Pres of EMEA & Latin American Region
  • Mr. Anthony Manna, Pres of Americas Region

What is Cochlear's stock price today?

One share of COH stock can currently be purchased for approximately A$201.64.

How big of a company is Cochlear?

Cochlear has a market capitalization of $11.06 billion.

What is Cochlear's official website?

The official website for Cochlear is http://www.cochlear.com/wps/wcm/connect/au/home.

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company can be reached via phone at +61-2-94286555.


MarketBeat Community Rating for Cochlear (ASX COH)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  191 (Vote Underperform)
Total Votes:  282
MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote "Outperform" if you believe COH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel